5U6V | pdb_00005u6v

X-ray crystal structure of 1,2,3-triazolobenzodiazepine in complex with BRD2(D2)


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.77 Å
  • R-Value Free: 
    0.193 (Depositor), 0.192 (DCC) 
  • R-Value Work: 
    0.155 (Depositor), 0.158 (DCC) 
  • R-Value Observed: 
    0.159 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 5U6V

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Design, Synthesis, and Biological Activity of 1,2,3-Triazolobenzodiazepine BET Bromodomain Inhibitors.

Sharp, P.P.Garnier, J.M.Hatfaludi, T.Xu, Z.Segal, D.Jarman, K.E.Jousset, H.Garnham, A.Feutrill, J.T.Cuzzupe, A.Hall, P.Taylor, S.Walkley, C.R.Tyler, D.Dawson, M.A.Czabotar, P.Wilks, A.F.Glaser, S.Huang, D.C.S.Burns, C.J.

(2017) ACS Med Chem Lett 8: 1298-1303

  • DOI: https://doi.org/10.1021/acsmedchemlett.7b00389
  • Primary Citation Related Structures: 
    5U6V

  • PubMed Abstract: 

    A number of diazepines are known to inhibit bromo- and extra-terminal domain (BET) proteins. Their BET inhibitory activity derives from the fusion of an acetyl-lysine mimetic heterocycle onto the diazepine framework. Herein we describe a straightforward, modular synthesis of novel 1,2,3-triazolobenzodiazepines and show that the 1,2,3-triazole acts as an effective acetyl-lysine mimetic heterocycle. Structure-based optimization of this series of compounds led to the development of potent BET bromodomain inhibitors with excellent activity against leukemic cells, concomitant with a reduction in c- MYC expression. These novel benzodiazepines therefore represent a promising class of therapeutic BET inhibitors.


  • Organizational Affiliation
    • Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia.

Macromolecule Content 

  • Total Structure Weight: 13.63 kDa 
  • Atom Count: 1,079 
  • Modeled Residue Count: 109 
  • Deposited Residue Count: 110 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Bromodomain-containing protein 2110Homo sapiensMutation(s): 0 
Gene Names: BRD2KIAA9001RING3
UniProt & NIH Common Fund Data Resources
Find proteins for P25440 (Homo sapiens)
Explore P25440 
Go to UniProtKB:  P25440
PHAROS:  P25440
GTEx:  ENSG00000204256 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP25440
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.77 Å
  • R-Value Free:  0.193 (Depositor), 0.192 (DCC) 
  • R-Value Work:  0.155 (Depositor), 0.158 (DCC) 
  • R-Value Observed: 0.159 (Depositor) 
Space Group: P 21 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 52.617α = 90
b = 71.743β = 90
c = 31.935γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2017-12-13
    Type: Initial release
  • Version 1.1: 2018-01-03
    Changes: Database references
  • Version 1.2: 2024-03-06
    Changes: Data collection, Database references